Core Viewpoint - 康臣药业 has announced the expiration of its 2013 Share Option Scheme, which will no longer offer or grant options after December 1, 2023, and has proposed a new 2024 Share Option Scheme to incentivize eligible participants starting January 1, 2023 [1] Summary by Relevant Sections - 2013 Share Option Scheme - The 2013 Share Option Scheme was adopted on December 2, 2013, and is valid for 10 years until December 1, 2023 - As of the announcement date, there are 50.4639 million options granted but not yet exercised under this scheme [1] - 2024 Share Option Scheme Proposal - The board recommends adopting the 2024 Share Option Scheme in accordance with the revised Listing Rules Chapter 17 - The new scheme aims to incentivize or reward eligible participants for their contributions to the group, effective from January 1, 2023 [1]
康臣药业(01681)建议采纳2024年购股权计划